Enact Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Enact Holdings (ACT).

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

1Buy

3Hold

2Sell

Consensus RatingBuy# Analysts6Avg. Consensus PT$44Upside to Avg. PT-9.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	B of A Securities	Mihir Bhatia	Downgrade	Buy→Underperform	$53→$42
Oct 12, 2026	JP Morgan	Richard Shane	Downgrade	Neutral→Underweight	$48→$44
Aug 10, 2026	Keefe, Bruyette & Woods	Bose George	PT Raise	Market Perform	$44→$49
Aug 7, 2026	RBC Capital	Rowland Mayor	PT Raise	Sector Perform	$46→$50
Aug 7, 2026	JP Morgan	Richard Shane	PT Raise	Neutral	$46→$48
Jul 13, 2026	JP Morgan	Richard Shane	PT Raise	Neutral	$45→$46
Jun 25, 2026	RBC Capital	Rowland Mayor	Initiate	Sector Perform	$46
Apr 21, 2026	B of A Securities	Mihir Bhatia	PT Raise	Buy	$48→$49
Feb 5, 2026	JP Morgan	Richard Shane	PT Raise	Neutral	$40→$44
Feb 5, 2026	Keefe, Bruyette & Woods	Bose George	PT Raise	Market Perform	$43→$44
Jan 12, 2026	JP Morgan	Richard Shane	PT Raise	Neutral	$39→$40
Dec 18, 2025	Keefe, Bruyette & Woods	Bose George	PT Raise	Market Perform	$42→$43
Nov 7, 2025	JP Morgan	Richard Shane	PT Cut	Neutral	$40→$39
Aug 11, 2025	JP Morgan	Richard Shane	PT Raise	Neutral	$35→$37
Jul 11, 2025	JP Morgan	Richard Shane	PT Raise	Neutral	$37→$39
Jul 7, 2025	Keefe, Bruyette & Woods	Bose George	PT Raise	Market Perform	$39→$40
May 5, 2025	UBS	Douglas Harter	PT Raise	Neutral	$38→$40
May 5, 2025	Keefe, Bruyette & Woods	Bose George	Downgrade	Outperform→Market Perform	$39
Apr 8, 2025	Keefe, Bruyette & Woods	Bose George	PT Cut	Outperform	$41→$39
Jan 14, 2025	JP Morgan	Richard Shane	PT Cut	Neutral	$36→$35

Analyst Ratings News

PRO
B of A Securities Downgrades Enact Holdings to Underperform, Lowers Price Target to $42

B of A Securities analyst Mihir Bhatia downgrades Enact Holdings (NASDAQ:ACT) from Buy to Underperform and lowers the price target from $53 to $42.

Benzinga Newsdesk

This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Analysts downgraded UWMC, ACT, ROIV, INSM; ACT’s target fell to $44.

Avi Kapoor

PRO
JP Morgan Downgrades Enact Holdings to Underweight, Lowers Price Target to $44

JP Morgan analyst Richard Shane downgrades Enact Holdings (NASDAQ:ACT) from Neutral to Underweight and lowers the price target from $48 to $44.

Benzinga Newsdesk

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Enact Holdings, Raises Price Target to $49

Keefe, Bruyette & Woods analyst Bose George maintains Enact Holdings (NASDAQ:ACT) with a Market Perform and raises the price target from $44 to $49.

Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Enact Holdings, Raises Price Target to $50

RBC Capital analyst Rowland Mayor maintains Enact Holdings (NASDAQ:ACT) with a Sector Perform and raises the price target from $46 to $50.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Enact Holdings, Raises Price Target to $48

JP Morgan analyst Richard Shane maintains Enact Holdings (NASDAQ:ACT) with a Neutral and raises the price target from $46 to $48.

Benzinga Newsdesk

Enact Holdings Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Enact Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
B of A Securities Downgrades Enact Holdings to Underperform, Lowers Price Target to $42

This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

PRO
JP Morgan Downgrades Enact Holdings to Underweight, Lowers Price Target to $44

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Enact Holdings, Raises Price Target to $49

PRO
RBC Capital Maintains Sector Perform on Enact Holdings, Raises Price Target to $50

PRO
JP Morgan Maintains Neutral on Enact Holdings, Raises Price Target to $48

People Also Watch

People Also Watch

Enact Holdings Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Enact Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROB of A Securities Downgrades Enact Holdings to Underperform, Lowers Price Target to $42

This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

PROJP Morgan Downgrades Enact Holdings to Underweight, Lowers Price Target to $44

PROKeefe, Bruyette & Woods Maintains Market Perform on Enact Holdings, Raises Price Target to $49

PRORBC Capital Maintains Sector Perform on Enact Holdings, Raises Price Target to $50

PROJP Morgan Maintains Neutral on Enact Holdings, Raises Price Target to $48

People Also Watch

People Also Watch

PRO
B of A Securities Downgrades Enact Holdings to Underperform, Lowers Price Target to $42

PRO
JP Morgan Downgrades Enact Holdings to Underweight, Lowers Price Target to $44

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Enact Holdings, Raises Price Target to $49

PRO
RBC Capital Maintains Sector Perform on Enact Holdings, Raises Price Target to $50

PRO
JP Morgan Maintains Neutral on Enact Holdings, Raises Price Target to $48